These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3003627)

  • 1. Enhancement of transmission at the frog neuromuscular junction by adenosine deaminase: evidence for an inhibitory role of endogenous adenosine on neuromuscular transmission.
    Sebastião AM; Ribeiro JA
    Neurosci Lett; 1985 Dec; 62(2):267-70. PubMed ID: 3003627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the role, inactivation and origin of endogenous adenosine at the frog neuromuscular junction.
    Ribeiro JA; Sebastião AM
    J Physiol; 1987 Mar; 384():571-85. PubMed ID: 2821240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diazepam enhances the inhibitory action of adenosine on transmission at the frog neuromuscular junction.
    De Mendonça A; Ribeiro JA
    Eur J Pharmacol; 1989 May; 164(2):347-54. PubMed ID: 2547637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATP released together with acetylcholine as the mediator of neuromuscular depression at frog motor nerve endings.
    Redman RS; Silinsky EM
    J Physiol; 1994 May; 477(Pt 1):117-27. PubMed ID: 8071878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the adenosine receptor and adenosine inactivation at the rat diaphragm neuromuscular junction.
    Sebastião AM; Ribeiro JA
    Br J Pharmacol; 1988 May; 94(1):109-20. PubMed ID: 2456805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between adenosine and phorbol esters or lithium at the frog neuromuscular junction.
    Sebastião AM; Ribeiro JA
    Br J Pharmacol; 1990 May; 100(1):55-62. PubMed ID: 2164862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of kava on neuromuscular transmission and muscle contractility.
    Singh YN
    J Ethnopharmacol; 1983 May; 7(3):267-76. PubMed ID: 6308355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presymptomatic and symptomatic ALS SOD1(G93A) mice differ in adenosine A1 and A2A receptor-mediated tonic modulation of neuromuscular transmission.
    Nascimento F; Sebastião AM; Ribeiro JA
    Purinergic Signal; 2015 Dec; 11(4):471-80. PubMed ID: 26335190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postsynaptic inhibition of the frog neuromuscular transmission by prostaglandin E1.
    Tsurusaki M; Tokimasa T; Akasu T
    Neurosci Lett; 1987 Jun; 77(3):303-7. PubMed ID: 3039417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presynaptic effects of cholecystokinin octapeptide on neuromuscular transmission in the frog.
    Akasu T; Tsurusaki M; Ariyoshi M
    Neurosci Lett; 1986 Jun; 67(3):329-33. PubMed ID: 3016613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of thiamine on neuromuscular transmission in the frog].
    Romanenko AV
    Neirofiziologiia; 1985; 17(6):794-800. PubMed ID: 3003595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Seasonal changes in neuromuscular transmission in experiments on dissected or curarized frog muscles].
    Dobretsov MG; Bereznikovskaia EIu; Vinogradova IM
    Neirofiziologiia; 1990; 22(6):745-51. PubMed ID: 1965851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenytoin reduces frequency potentiation of synaptic potentials at the frog neuromuscular junction.
    Selzer ME; David G; Yaari Y
    Brain Res; 1984 Jun; 304(1):149-52. PubMed ID: 6744034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification by lithium of transmitter release at the neuromuscular junction of the frog.
    Branisteanu DD; Volle RL
    J Pharmacol Exp Ther; 1975 Aug; 194(2):362-72. PubMed ID: 239225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long release latencies are increased by acetylcholine at frog endplate.
    Samigullin D; Bukharaeva EA; Nikolsky E; Adámek S; Vyskocil F
    Physiol Res; 2003; 52(4):475-80. PubMed ID: 12899661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of delta-9-tetrahydrocannabinol, 11-hydroxy-delta-9-tetrahydrocannabinol and cannabidiol on neuromuscular transmission in the frog.
    Turkanis SA; Karler R
    Neuropharmacology; 1986 Nov; 25(11):1273-8. PubMed ID: 3025765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the type of receptor involved in the inhibitory action of adenosine at the neuromuscular junction.
    Ribeiro JA; Sebastião AM
    Br J Pharmacol; 1985 Apr; 84(4):911-8. PubMed ID: 2988684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. At the frog neuromuscular junction prostaglandin synthase inhibitors depress and PGE partially restores quantal acetylcholine release.
    Madden KS; van der Kloot W
    Brain Res; 1982 Feb; 234(2):464-8. PubMed ID: 6277436
    [No Abstract]   [Full Text] [Related]  

  • 19. Predominance of adenosine excitatory over inhibitory effects on transmission at the neuromuscular junction of infant rats.
    Pousinha PA; Correia AM; Sebastião AM; Ribeiro JA
    J Pharmacol Exp Ther; 2010 Jan; 332(1):153-63. PubMed ID: 19789361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of prostaglandins E1 and F2 alpha on neuromuscular transmission in the frog sartorius muscle.
    Illés P; Magazanik LG; Knoll J
    Acta Physiol Acad Sci Hung; 1977; 49(3-4):235-9. PubMed ID: 225925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.